Estimating the Dollar Value of Health Outcomes from Drug-Abuse Interventions
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: People who abuse drugs suffer from a host of medical problems that impose costs on both the abusers and society as a whole. Drug-abuse treatment and other interventions can help alleviate these medical problems, leading to health status improvements for chronic drug users and reduced social costs. The authors' dual purpose here is to (1) propose a theoretically rigorous yet easy-to-apply methodology for estimating the health-related costs of drug abuse and (2) demonstrate the methodology by estimating the potential dollar value of avoiding adverse health consequences as a result of successful drug-abuse interventions. METHODS: The authors' proposed multiattribute quality-adjusted life year methodology for estimating the value of avoiding morbidity and mortality involves eight steps to be followed sequentially. The framework is based on developing a common unit of well-being (i.e., quality-adjusted life year) that can be applied to all types of health conditions. If all health states can be denominated in this common unit, then the process of valuation is straightforward and consistent across all types of illnesses and diseases. The methodology is relatively inexpensive to execute because the estimation procedures are not complicated technically and the data demands are modest. Also, this approach incorporates elements from several disciplines, including psychology, epidemiology, medicine, and economics. Finally, the proposed methodology is flexible enough to cover a wide range of illnesses and diseases so that consistent and comparable estimates can be generated. RESULTS: The authors estimate the dollar value of avoiding acute hepatitis B, human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hypertension, bacterial pneumonia, sexually transmitted diseases, and tuberculosis for a white male aged 32 years. The authors' results illustrate that estimated avoided morbidity values can vary significantly across the range of health consequences associated with drug abuse. At the upper end of the range, the value of avoiding only the morbidity associated with a single case of HIV/AIDS is approximately $157,811 for the period beginning with transmission of HIV, through late-stage HIV and AIDS, and ending just before death. CONCLUSIONS: People who abuse drugs suffer from many medical problems in addition to their addiction. The proposed approach for estimating the dollar value of avoiding adverse health consequences provides policy analysts, evaluators, and researchers a method to calculate theoretically based benefit estimates for use in a benefit-cost analysis of drug-abuse interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Contingent Valuation: Is Some Number Better than No Number?
Diamond, P. A., & Hausman, J. A. (1994) · Journal of Economic Perspectives · doi:10.1257/jep.8.4.45 · Cited by 1,894
Risk factors for syphilis: cocaine use and prostitution.
Rolfs, R. T., Goldberg, M., & Sharrar, R. G. (1990) · American Journal of Public Health · doi:10.2105/ajph.80.7.853 · Cited by 241
Cherubin, C. E., & Sapira, J. D. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00009 · Cited by 238
Financing and cost of standard and enhanced methadone treatment
Bradley, C. J., French, M. T., & Rachal, J. V. (1994) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(94)90096-5 · Cited by 52
Self-citationCost analysis of training and employment services in methadone treatment
French, M. T., Bradley, C. J., Calingaert, B., Dennis, M. L., & Karuntzos, G. T. (1994) · Evaluation and Program Planning · doi:10.1016/0149-7189(94)90048-5 · Cited by 40
Self-citation
Cited by
Contingent Valuation: Is Some Number Better than No Number?
Diamond, P. A., & Hausman, J. A. (1994) · Journal of Economic Perspectives · doi:10.1257/jep.8.4.45 · Cited by 1,894
Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello, B., et al. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.721 · Cited by 1,255
“In addition, psychiatric and drug-use disorders produce substantial social burden(11,12) and can increase health care costs.(13-16) Population-based estimates of the prevalence of these disorders among people with HIV and factors associated with them are important for the development of policies and programs that will…”
BackgroundThe cost of crime to society: New crime-specific estimates for policy and program evaluation
McCollister, K. E., French, M. T., & Fang, H. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.12.002 · Cited by 584
Self-citationBenefit-Cost Analysis of Brief Physician Advice With Problem Drinkers in Primary Care Settings
Fleming, M. F., Mundt, M. P., French, M. T., Manwell, L. B., Stauffacher, E. A., & Barry, K. L. (2000) · Medical Care · doi:10.1097/00005650-200001000-00003 · Cited by 355
Self-citationMethods for the analysis of quality-of-life and survival data in health technology assessment.
Billingham, Abrams, & Jones (1999) · Health Technology Assessment · doi:10.3310/hta3100 · Cited by 307
Metadata
- Authors
- FRENCH, M. T., MAUSKOPF, J. A., TEAGUE, J. L., & ROLAND, E. J.
- Venue
- Medical Care
- Published
- 1996-09
- Volume
- 34
- Issue
- 9
- Pages
- 890-910
- ISSN
- 0025-7079 (ISSN-L)
- OpenAlex
- W2092498375
- Cited by
- 84
- References
- 5
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimating the Dollar Value of Health Outcomes from Drug-Abuse Interventions. https://app.cochat.ai/papers/10.1097/00005650-199609000-00003
- The paper
- FRENCH, M. T., MAUSKOPF, J. A., TEAGUE, J. L., & ROLAND, E. J. (1996). Estimating the Dollar Value of Health Outcomes from Drug-Abuse Interventions. Medical Care. https://doi.org/10.1097/00005650-199609000-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.